These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14505601)

  • 1. Ceiling and floor effects in sleep research.
    Youngstedt SD
    Sleep Med Rev; 2003 Aug; 7(4):351-65. PubMed ID: 14505601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Contribution of zolpidem in the management of sleep disorders].
    Lavoisy J; Zivkovic B; Benavides J; Perrault GH; Robert P
    Encephale; 1992; 18(4):379-92. PubMed ID: 1363657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selective extrasynaptic GABAA agonist, gaboxadol, improves traditional hypnotic efficacy measures and enhances slow wave activity in a model of transient insomnia.
    Walsh JK; Deacon S; Dijk DJ; Lundahl J
    Sleep; 2007 May; 30(5):593-602. PubMed ID: 17552374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can an inert sleeping pill affect sleep? Effects on polysomnographic, behavioral and subjective measures.
    Fratello F; Curcio G; Ferrara M; Marzano C; Couyoumdjian A; Petrillo G; Bertini M; De Gennaro L
    Psychopharmacology (Berl); 2005 Oct; 181(4):761-70. PubMed ID: 15986193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug development for sleep therapeutics - A Marcus Evans conference.
    Lew R
    IDrugs; 2008 Apr; 11(4):245-9. PubMed ID: 18379954
    [No Abstract]   [Full Text] [Related]  

  • 6. Sleep disorders in older adults.
    Saccomano SJ
    J Gerontol Nurs; 2014 Mar; 40(3):38-45. PubMed ID: 24219077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective versus objective evaluation of hypnotic efficacy: experience with zolpidem.
    Kryger MH; Steljes D; Pouliot Z; Neufeld H; Odynski T
    Sleep; 1991 Oct; 14(5):399-407. PubMed ID: 1759092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypnotic use and fatigue in multiple sclerosis.
    Braley TJ; Segal BM; Chervin RD
    Sleep Med; 2015 Jan; 16(1):131-7. PubMed ID: 25454981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
    Walsh JK; Salkeld L; Knowles LJ; Tasker T; Hunneyball IM
    Sleep Med; 2010 Jan; 11(1):23-30. PubMed ID: 19945340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter study of sleep-wake rhythm disorders: therapeutic effects of vitamin B12, bright light therapy, chronotherapy and hypnotics.
    Yamadera H; Takahashi K; Okawa M
    Psychiatry Clin Neurosci; 1996 Aug; 50(4):203-9. PubMed ID: 9201777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single dose of hypnotic corrects sleep and EEG abnormalities in symptomatic Huntington's disease mice.
    Kantor S; Varga J; Morton AJ
    Neuropharmacology; 2016 Jun; 105():298-307. PubMed ID: 26805423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical treatments.
    Shapiro CM
    J Psychosom Res; 1999 Oct; 47(4):291-2. PubMed ID: 10616223
    [No Abstract]   [Full Text] [Related]  

  • 14. A WASO sub-group analysis of a 6-month study of eszopiclone 3 mg.
    Krystal AD; Huang H; Zummo J; Grinnell T; Marshall RD
    Sleep Med; 2012 Jun; 13(6):691-6. PubMed ID: 22465450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep quality and the use of benzodiazepine hypnotics in general practice.
    Krska J; MacLeod TN
    J Clin Pharm Ther; 1995 Apr; 20(2):91-6. PubMed ID: 7650080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient Background Factors Affecting the Therapeutic Outcomes in Response to Eszopiclone in Adult Patients with Chronic Insomnia: A Post Hoc Analysis of a Double-Blind Phase III Study in Japan.
    Inoue Y; Kamijo A; Nagai R
    J Clin Sleep Med; 2015 Oct; 11(10):1171-8. PubMed ID: 26094929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of actigraphy and polysomnography in older adults treated for chronic primary insomnia.
    Sivertsen B; Omvik S; Havik OE; Pallesen S; Bjorvatn B; Nielsen GH; Straume S; Nordhus IH
    Sleep; 2006 Oct; 29(10):1353-8. PubMed ID: 17068990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ethanol on sleep-awake state in sleep-disturbed rats.
    Obara Y; Tsutsui R; Ishida T; Kamei C
    Biol Pharm Bull; 2010; 33(5):849-53. PubMed ID: 20460765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are poor sleepers changed into good sleepers by hypnotic drugs?
    Adam K
    Psychopharmacology Suppl; 1984; 1():44-55. PubMed ID: 6382254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sleep disorders and sedative-hypnotic medications on health-related quality of life in dialysis patients.
    Zheng C; Xu J; Chen C; Lin F; Shao R; Lin Z; Liu Y; Zhou Y
    Int Urol Nephrol; 2019 Jan; 51(1):163-174. PubMed ID: 30467784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.